On 14 May 2014
Astec Lifesciences announced that a meeting of the Board of Directors of the Company will be held on 14 May 2014, inter alia, to consider and approve the Standalone & Consolidated Audited Accounts for the Quarter & Year Ended 31 March 2014, after these accounts are reviewed by Audit Committee and to recommend dividend on equity shares for the year ended 31 March 2014, if any.Powered by Capital Market - Live News